Feedback / Questions
Sartate (67Cu MeCOSar octreotate) - Clarity Pharma
https://www.prnewswire.co.uk/news-releases/clarity-pharmaceuticals-announces-that-the-us-fda-grants-rare-pediatric-disease-designation-to-67cu-sartate-tm-for-the-treatment-of-neuroblastoma-877781623.html
Jun 3, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next